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Abstract 
Ibandronate sodium (IBN) [(1-hydroxy-3- (methyl pentyl amino) propylidene 
bisphosphonic acid monosodium monohydrate)] is the sodium salt of ibandronic acid, a 
synthetic nitrogen-containing bisphosphonate drug. The aim of this study was to develop a 
sensitive and accurate RP-HPLC method with indirect UV detection for determination of 
IBN in pharmaceutical formulations. Chromatographic separation was performed on a 
Waters Bridge C18 reversed-phase column (250 X 4.6 mm I.D.; particle size 5 µm), in an 
isocratic mode with a mobile phase constituted of 90% buffer: 10% acetonitrile (V/V). The 
buffer was made using 1.5 mL ortho-phosphoric acid, 990 mg 1-Hexanesulfonic acid sodium 
salt 98%, 140 mg EDTA in 1000 mL flask diluted with HPLC grade water. The elution was 
carried out at a flow rate of 1.0 mL minˉ1. A diode array detector measured the UV 
absorbance at 198 nm, in inverse mode. The method was validated for specificity/selectivity, 
linearity, LOD, LOQ, accuracy, precision and robustness according to ICH validation 
guidelines. The limits of detection and quantification were calculated at 0.0163 µg/mL and 
0.0495 µg/mL, respectively. The method was effectively used for determination of IBN from 
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commercial tablets and provided good results without any interference from commonly used 
excipients. 
Keywords: RP-HPLC with indirect UV detection, Ibandronate sodium, validation, 
pharmaceuticals 
 
Introduction 
 Ibandronate sodium (IBN) is the sodium salt form of ibandronic acid, a synthetic 
nitrogen-containing bisphosphonate (Fig. 1). Ibandronic acid inhibits farnesyl pyrophosphate 
synthase, resulting in a reduction in geranylgeranyl GTPase signaling proteins and apoptosis 
of osteoclasts. This agent increases bone mineral density, decreases bone remodeling, inhibits 
osteoclast-mediated bone resorption, and reduces metastases-related and corticosteroid-
related bone pain (Bausset al., 2002; Black et al., 2007). 
 For quantification of IBN in pharmaceutical formulations, few analytical methods 
have been reported. Determination of bisphosphonates by high-performance liquid 
chromatography (HPLC) with UV or fluorescence detection is hindered because of the lack 
of chromophores groups in their structures. Several analytical methods using refractive index 
or electrochemical detection were described in the literature (Brooks et al., 1992; Denhartigh 
et al., 1993; Han et al., 1996; Higuchiet al., 1992). However, these detection systems are not 
common in most of the routine analytical laboratories. Analytical methods for quantification 
of bisphosphonates using UV/VIS or fluorescence detectors in the indirect mode, or after 
pre- or post-column derivatization, have also been described (Brezovska et al., 2010; Biffar 
et al., 1989; Dansereau et al., 2001; Hartigh et al., 1997; Lovdahl et al., 1999; Kosonen, 
1992). However, the derivatization step is time and solvent consuming, making this process 
inappropriate for routine analysis. 
 
Fig. 1. The structure of IBN. 
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 Therefore, the aim of this study was to develop a RP-HPLC method with indirect UV 
detection which would replace the existing commercial methods with RI detector. 
 
Materials and methods 
Instruments and reagents 
 HPLC analyses were performed using a Schimadzu LC-2010 chromatographic 
system (Schimadzu, Kyoto, Japan) consisting of a LC-20AT Prominence liquid 
chromatograph pump with DGU-20A5 Prominence degasser, a SPD-M20A Prominence 
Diode Array Detector, RF 10AXI fluorescence detector and a SIL-20 AC Prominence auto 
sampler. Data analyses were done using Class VP 7.3 Software. The UV spectra of IBN 
dissolved in mobile phase were recorded on the Shimadzu UV-Visible spectrophotometer 
(UV-1800). 
 IBN working standard was obtained from Maprimed SA. HPLC-grade acetonitrile 
was from Merck (Darmstadt, Germany). Double-distilled water was used to prepare mobile 
phase solutions. All solvents and solutions for HPLC analysis were filtered through a 
membrane filter (0.45 µm pore size) and vacuum degassed before use.  
 
Chromatographic conditions 
 Chromatographic separation was performed on a Waters Bridge C18 reversed-phase column 
(250 X 4.6 mm I.D.; particle size 5 µm), in an isocratic mode with a mobile phase constituted of 90% 
buffer: 53% acetonitrile (V/V). The buffer was made using 1.5 mL ortho-phosphoric acid, 990 mg 1-
Hexanesulfonic acid sodium salt 98%, 140 mg EDTA in 1000-mL flask diluted with HPLC grade 
water. The elution was carried out at a flow rate of 1.0 mL minˉ1. All analyses were performed at 
room temperature (25 °C+/- 2 °C). A diode array detector measured the UV absorbance at 198 nm, 
in inverse mode. 
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Calibration curve  
 Stock solution was prepared by dissolving IBN standard substance (10 mg) with 
mobile phase in 10 mL volumetric flask (c=1 mg/mL) and stored at room temperature (25 °C 
+/- 2 °C) during the study. Standard solutions were prepared by dilution of IBN stock solution 
with solvent (mobile phase) to obtain final concentrations ranging from 25–200 µg/mL (25, 
30, 40, 45, 50, 55, 60, 75 and 200 µg/mL). Mobile phase was used as a blank. 
 
Sample preparation 
 Twenty tablets containing IBN active substance were weighted, crushed, powdered 
and grinded finely. A portion of the powder equivalent to 10 mg of IBN was used and diluted 
with mobile phase to obtain a working concentration of 50 µg/mL. The sample solution was 
filtered through 0.45 nylon membrane filter before use. The amount of IBN per tablet was 
calculated using the standard calibration curve. 
 
Results and discussion 
 Indirect UV detection is a method that is used typically when detecting analytes don’t 
have chromophore present in their structure. Indirect UV detection allows measurement of 
non-UV-absorbing anions without derivatization. An ionic chromophore is placed in the 
mobile phase, and the decrease in absorbance observed when an analyte ion displacing the 
chromophore ion in the mobile phase is monitored (Brezovska et al., 2010). As there is no 
chromophore present in IBN, the detection of a UV transparent analyte is accomplished by 
adding light ionic (ion-pairing) species into the mobile phase. Ibandronate poses analytical 
challenges for reversed-phase HPLC due to the presence of two polar phosphonate groups. 
This makes retention on commonly used RP columns difficult (Gawad et al., 2013). In 
addition, the metal chelation property of ibandronate can cause poor peak shape and analyte 
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recovery in systems that are not metal-free. Chelating agents, such as 
ethylenediaminetetraacetic acid (EDTA), are added to the mobile phase to prevent metal 
contaminants from chelating with ibandronate (Furuta et al., 1993). EDTA was used as a 
complexing agent in combination with ion-pairing agent (1-hexanesulfonic acid sodium salt) 
that will separate the analyte and give good absorption, to enable retention and separation on 
a RP column.  
 In the preliminary research, the absorption spectra of IBN were studied using 
Shimadzu UV-Visible spectrophotometer. Solution of IBN substance was dissolved in 
mobile phase and was scanned within the wavelength region from 300–190 nm against the 
mobile phase as a blank. The UV spectrum of the IBN dissolved in mobile phase shows an 
absorption maximum at 198 nm.  
Fig. 2. UV spectrum of IBN in mobile phase in the range of 300 to 190 nm. 
 
Method validation 
 One of the most important steps in analytical determination is validation of the 
method for quantitative analysis. The method was validated for specificity/selectivity, 
linearity, LOD, LOQ, accuracy, precision and robustness. The ICH guideline was used to 
validate the proposed method (ICH, 2005). 
 
Specificity and selectivity   
 Specificity is the ability to asses unequivocally the analyte in the presence of 
components which might be expected during the analysis. The analytes should have no 
interference from other components such as impurities and degradation products, and they 
should be remarkably separated from IBN (ICH, 2005; McMaster, 2007). This method 
showed that it is quite selective and showed great resolution between IBN and the given 
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impurities (the sample solution was spiked with ibanic acid). There was no other interfering 
peak around the retention time of IBN. Also, the baseline did not show any significant noise. 
Fig. 3. Chromatogram of sample solution spiked with Ibanic acid with indirect UV 
detection. 
Fig. 4. Chromatogram of IBN standard solution with indirect UV detection (c = 50 µg/mL). 
Fig. 5. Chromatogram of IBN sample solution with indirect UV detection (c = 50 µg/mL). 
Fig. 6. Chromatogram of blank solution. 
 
Linearity and range 
 For evaluation of linearity, the peak area and concentrations were subjected to a least square 
regression analysis to calculate calibration equation and determination coefficient. For the proposed 
method, the calibration graphs of the absorbance against concentration were found to be linear over 
therange of 25–200 µg/mL at the appropriate experimental conditions. The equation for linear 
regression was: y = 17352x - 8657.1; R² = 0.9991, where X is the concentration (in µg/mL) of IBN 
and Y is the absorbance. Without an intersection of the estimated tilt value at 95% of the reliability 
of the boundary, optionally the calibration lines of IBN solutions in mobile phase are not deviate from 
sources as above obtained values fall within the limits of reliability. 
 
Limit of detection & quantitation limit  
 The detection limit in a single analytical procedure is the amount of analyte in a 
sample that can be detected, but not necessarily quantified as an accurate value. The 
quantitation limit of an individual analytical procedure is the amount of analyte in a sample 
that can be quantitatively determined by proper precision and accuracy. The LOD and LOQ 
were found using the ratio 3.3 σ/S and 10 σ/S respectively, where σ is the standard error of 
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estimation and S is slope (ICH, 2005). The established LOD and LOQ for ibandronic acid 
sodium were 0.0163 µg/mL and 0.0495 µg/mL respectively. 
 
Accuracy 
 To study the accuracy of the proposed analytical methods, recovery tests were 
conducted using the standard addition method. To discover whether excipients interfered 
with the analysis, known amounts of standard were added to tablet formulation samples and 
the resulting mixtures were analyzed by the proposed methods. The percent of recovery was 
calculated using the calibration equation. Different concentrations of IBN standard solution 
(containing IBN active substance in the range of 80, 100 and 120% of the working 
concentration) within the used range of linearity and the calculated values were as a 
supplement to the previously analyzed formulation concentration of 50 µg/mL with 
percentage recovery. 
Recovery values (Table 3) obtained from the determination of IBN in commercial 
tablets using the method of standard additions confirmed that the method was accurate and 
precise in the range of 80–120% of the working concentration.  
 
Table 1. Results obtained from testing the accuracy of the method 
 
Precision 
 The precision of the analytical procedure (intra-assay precision) was investigated by 
analyzing six sample solutions obtained by multiple sampling of the same homogeneous 
sample under the prescribed conditions (at 100% of the working concentration of IBN (50 
µg/mL) on the same day, by the same analyst and using the same equipment. The 
intermediate precision of the analytical procedure was investigated by analyzing sample 
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solutions on three consecutive days. The precision of the analytical procedure was expressed 
as a relative standard deviation of series of measurements. 
 
Table 2. Results of the precision of the method 
 
Robustness 
 Robustness should show the reliability of an analysis with respect to deliberate 
variations in method parameters. If measurements are susceptible to variations in analytical 
conditions, the analytical conditions should be suitably controlled, or a precautionary 
statement should be included in the procedure. One consequence of the evaluation of 
robustness should be that a series of system suitability parameters (e.g., resolution test) is 
established to ensure that the validity of the analytical procedure is maintained whenever 
used. For this method variations were made to the column temperature, flow-rate and 
variation in the organic part in the mobile phase. The effects of the following changes in 
chromatographic conditions didn’t show any significant changes.  
 
Table 3. Results of the robustness of the method 
 
 
Conclusion  
 A simple RP-HPLC method with indirect UV detection was developed and validated 
for determination of IBN in tablets. The validation results showed that the method is 
selective, linear, precise, accurate, and with a high sensitivity. The proposed method gives a 
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simple and economic approach that can be easily applied for routine control of IBN in 
pharmaceuticals. 
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Резиме 
Реверзо-фазенHPLCметод со индиректна UV детекција за определување на 
натриум ибандронат во фармацевстки препарати 
 
Жарко Тантуровски1,Зорица Арсова-Сарафиновска1, Анета Димитровска2 
 
1Институт за Јавно Здравје на Република Македонија, 50та Дивизија бр.6,  
1000 Скопје, Република Македонија 
2Институт за Применета Хемија и Фармацевтски анализи,  
Фармацевтски Факултет, Универзитет „Св Кирил и Методиј“, Мајка Тереза 47, 
1000 Скопје, Република Македонија 
 
Клучни зборови: RP-HPLC метод со индиректна UV детекција, натриум ибандронат,  
валидација, фармацевтски препарати 
 
 Натриум ибандронат [(1-hydroxy-3- (methyl pentyl amino) 
propylidenebisphosphonic acid monosodium monohydrate)] е натриумовата сол на 
ибандронската киселина, синтентска бифосфонатна супстанција што содржи азот. 
Целта на оваа студија беше да се развие осетлив и точен RP-HPLC метод со индиректна 
UV детекција, што може да се користи за определување на натриум ибандронат во 
фармацевтски препарати. Хроматографското раздвојување беше изведено на Waters 
Bridge C18 реверзно-фазна колона (250 X 4.6 mm I.D., со големина на честички 5 µm), 
во изократски услови при што како мобилна фаза беше користена мешавина од 90% 
пуфер:10% ацетонитрил. Пуферот е изработен од 1,5mL на ортофосфорна киселина 
85%, 990 mg натриумова сол на 1-Хексансулфонска киселина 98% и 140 mg на EDTA 
во 1000 mL стаклен сад, дополнет до волуменот со редестилирана вода со HPLC 
квалитет. Елуирањето е изведено при константен проток од 1,0 mL min-1. DAD 
детектор беше користен за мерење на UV абсорбанцата на 198 nm, во индиректна 
функција. Методот беше валидиран во однос на параметрите: 
специфичност/селективност, линеарност, LOD, LOQ, точност, прецизност и 
робусност, во согласност соICH водичот за валидирање на аналитички методи. 
doi:   Professional paper 
 
*Corresponding author: zharko.tanturovski@gmail.com 
   14 
 
 
Лимитот на детекција беше пресметан со вредност од 0,0163 µg/mL, додека лимитот 
на квантификација изнесува 0,0495 µg/mL. Методот беше успешно искористен за 
определување на ибандронат натриум во комерцијални таблети и даде добри резултати 
без било каква интерференција од ексципиенсите во формулацијата. 
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Fig. 1. Structure of IBN. 
 
 
 
 
Fig. 2. UV spectrum of IBNin mobile phase in the range of 300 to 190 nm. 
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Fig. 3. Chromatogram of sample solution spiked with Ibanic acid with indirect UV 
detection. 
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Fig. 4. Chromatogram of IBN standard solution with indirect UV detection (c = 50 µg/mL). 
 
Fig. 5. Chromatogram of IBN sample solution with indirect UV detection (c = 50 µg/mL). 
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Fig. 6. Chromatogram of blank solution. 
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Table 1. Results obtained from testing of the accuracy of the method 
Sample ID % Recovery  
 
 
80% of WC* 
99.21  
Average: 99.27% 
SD: 0.08% 
%RSD: 0.08% 
99.41 
99.24 
99.25 
99.33 
99.21 
100% of WC* 
 
99.62  
Average: 99.50% 
SD: 0.20% 
%RSD: 0.20% 
99.17 
99.67 
99.36 
99.62 
99.56 
120% of WC* 
 
100.56  
Average: 100.35% 
SD: 1.14% 
%RSD: 1.13% 
100.21 
100.36 
100.29 
100.26 
100.44 
*WC = working concentration 
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Table 2. Results of the precision of the method 
Sample ID Absorption  
100% of WC* 
 
869986 
Average: 869641.3 
%RSD: 0.036 
869279 
869774 
869511 
869321 
869977 
*WC = working concentration 
 
 
 
 
 
 
 
 
 
 
 
 
 
doi:   Professional paper 
 
*Corresponding author: zharko.tanturovski@gmail.com 
   21 
 
 
Table 3. Results of the robustness of the method 
Parameter RSD (%) (n = 
3) 
Flow rate (1.1 mL min–1) 0.091 
Flow rate (0.8 mL min–1) 0.093 
Organic solvent concentration 
(15%) 
0.542 
Organic solvent concentration 
(5%) 
0.078 
Column temperature (35 °C) 0.034 
Column temperature (45 °C) 0.086 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
